Links to all GeneRIF Items | 10643 |
PubMed (Gene Name) | Literature evidence |
|---|---|
| 17316760 (IGF2BP3) | study shows KOC is highly expressed in high-grade lung neuroendocrine carcinomas but not low- & intermediate-grade carcinoid tumors, indicating KOC may play an important role in regulation of biologic behavior of high-grade lung neuroendocrine carcinomas |
| 19427669 (IGF2BP3) | IMP3 could play a critical role in diagnosis of non-small cell lung cancer, identifying high-risk patients who might benefit from early and tailored systemic therapy. |
| 21838610 (IGF2BP3) | We review here the literature concerning IMP3 expression in lung neoplasms. IMP3 immunohistochemical expression was reported in 27-55% of cases of lung adenocarcinoma and in 75-90% of cases of lung squamous cell carcinoma. (review) |
| 23190601 (IGF2BP3) | expression of IMP3 correlates with solid subtype and with distant metastases regardless of histological subtype of lung adenocarcinoma. |
| 23661345 (IGF2BP3) | GLUT-1/KOC do not differentiate malignant mesotheliomas from pulmonary adenocarcinomas but can be useful in differentiating reactive mesothelial hyperplasia from malignant mesothelioma and lung adenocarcinoma. |
| 23837977 (IGF2BP3) | IMP3 expression predicts a poor prognosis in the patients with lung squamous cell carcinoma, so it can be used as a novel lung carcinoma biomarker. |
| 25337222 (IGF2BP3) | CK5/6, IMP3 and TTF1 immunostaining appears to be useful to improve the accuracy of cytological diagnoses between reactive mesothelial cells, metastatic adenocarcinoma of lung and non-lung origin in pleural effusion |
| 26608347 (IGF2BP3) | IMP3 appears to play an important role in tumor invasion in patients with lung adenocarcinoma and may serve as a useful prognostic biomarker in these patients. |
| 28381175 (IGF2BP3) | IGF2BP3 might play the most important role in tumor aggressiveness and prognosis in lung adenocarcinoma. |
| 29115542 (IGF2BP3) | Study found IMP3 frequently overexpressed in many human neoplasms and show significant associations with adverse tumor features in esophageal adenocarcinomas and cancers of the urinary bladder, lung, stomach, and pancreas. |
| 29209838 (IGF2BP3) | IMP3 is a strong prognostic factor in non-neuroendocrine brain metastases and in particular in patients with adenocarcinoma metastases.IMP3 expression is associated with poor prognosis in patients with non-small cell lung cancer brain metastases. |
| 33493403 (IGF2BP3) | Prognostic Impact of IGF2BP3 expression in Patients with Surgically Resected lung Adenocarcinoma. |